Ampio Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-11.091; its P/E ratio is -0.03; Ampio Pharmaceuticals is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ 1.92M	$ -1.23M	$ -1.37M	$ -3.98M	$ -2.29M
EBITDA	$ 1.92M	$ -1.23M	$ -1.37M	$ -3.86M	$ -2.11M
Net Income Common Stockholders	$ 1.92M	$ -1.23M	$ -1.37M	$ -3.98M	$ -2.21M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 4.10M	$ 6.40M	$ 7.00M	$ 10.40M	$ 12.65M
Total Assets	$ 5.74M	$ 7.65M	$ 9.20M	$ 10.78M	$ 13.59M
Total Debt	$ 274.00K	$ 362.00K	$ 448.00K	$ 532.00K	$ 614.00K
Net Debt	$ -3.83M	$ -6.04M	$ -6.55M	$ -9.87M	$ -12.04M
Total Liabilities	$ 2.38M	$ 2.27M	$ 2.59M	$ 2.86M	$ 1.80M
Stockholders Equity	$ 3.36M	$ 5.38M	$ 6.60M	$ 7.88M	$ 11.80M
Cash Flow	-
Free Cash Flow	$ -2.31M	$ -555.00K	$ -3.40M	$ -2.30M	$ -4.29M
Operating Cash Flow	$ -2.31M	$ -555.00K	$ -3.40M	$ -2.30M	$ -4.29M
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in USD

Ampio Pharmaceuticals Earnings and Revenue History

Income Statement >

Ampio Pharmaceuticals Debt to Assets

Balance Sheet >

Ampio Pharmaceuticals Cash Flow

Cash Flow >

Ampio Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing